Clinical Trial Update: A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease [Phase 2]

View source ↗

Summary

This document reports a Phase 2a multicenter clinical trial of TB006 in participants with Parkinson's disease. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• TB006

Snippet

Sponsor: TrueBinding, Inc. | Conditions: Parkinson's Disease (PD) | Phase 2 | Status: ACTIVE_NOT_RECRUITING